Investigation of Inhibition of Thrombospondin-1 ( TSP-1 ) Expression by Puerarin in Kidney of Diabetic

PAN Zhen-yu,XU Su-qin,BAO Zhao-sheng,SHEN Yue-liang,ZHANG Xiao-ming
2011-01-01
Abstract:OBJECTIVE: To investigate the inhibitory effect of puerarin on thrombospondin-1 (TSP-1) expression in kidney of diabetic rats, and to explore the mechanism of renal protection of puerarin. METHODS: Thirty adult Sprague-Dawley male rats were divided into 3 groups at random, i. e. diabetes group, puerarin treatment group and control group (n = 10). Diabetes group and puerarin treatment group were injected with streptozotocin to induce diabetes, then the rats in puerarin treatment group received intraperitoneal injection of puerarin at 80 mg·kg-1·d-1 for 4 weeks, while the rest 2 groups received intraperitoneal injection of saline at same dosage. After 4 weeks, the pathological changes of the kidneys in the 3 groups were inspected by HE staining. The thrombospondin-1 (TSP-1) protein and mRNA were detected by immunohistochemistry and RT-qPCR. RESULTS: Crucial typical changes of diabetic nephropathology, glomerular shrink, tubulo-interstitial and tubular epithelial cells vacuoles and granular degeneration, were observed by HE staining as compared to the puerarin threatment group. The expression of TSP-1 was significantly increased in the glomerular mesangial and epithelial cells in diabetic rats, while that in the puerarin treatmenth group was significantly inhibited. CONCLUSION: TSP-1 may play a major role in the process of diabetic nephropathy through angiotensin II-transforming growth factor-β pathway. Puerarin can inhibit the expression of TSP-1 thus to protect the diabetic rat's kidney.
What problem does this paper attempt to address?